Overview

Pharmacokinetics of Anacetrapib (MK0859) in Patients With Hepatic Insufficiency (MK-0859-039)

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the Area Under the Curve (AUC(0 to infinity)) of anacetrapib.
Phase:
Phase 1
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Anacetrapib
Oxazolidinones